Related Experiment Video
Updated: Jun 27, 2025

12:58
Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
Published on: September 12, 2019
9.8K
Aβ-protein polymerization in Alzheimer disease: Optimal control for nucleation parameter estimation
Ciuperca S Ionel1, Moncef Mahjoub2, Tine Léon Matar3
1Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR5208, Institut Camille Jordan, F-69603 Villeurbanne, France.
Journal of Theoretical Biology
|April 27, 2024
Summary
This study models Alzheimer's disease using the amyloid cascade hypothesis, focusing on the formation of toxic amyloid-beta (Aβ) oligomers. An optimal control method estimates the crucial nucleation rate, key to understanding this neurodegenerative disease.
Area of Science:
- Neuroscience
- Biophysics
- Mathematical Biology
Background:
- Alzheimer's disease is linked to the amyloid cascade hypothesis.
- Amyloid-beta (Aβ) protein oligomers are considered the primary pathogenic agents.
- The formation dynamics of Aβ oligomers involve Amyloid Precursor Protein (APP) cleavage and subsequent polymerization/nucleation.
Purpose of the Study:
- To model the formation dynamics of pathogenic Aβ oligomers.
- To propose an optimal control problem for estimating the nucleation rate.
- To investigate the role of nucleation in the amyloid cascade hypothesis.
Main Methods:
- Utilizing a Becker-Döring type model to describe Aβ formation dynamics.
- Developing an optimal control framework to estimate kinetic parameters.
- Focusing on the nucleation step, which lacks experimental measurement.
Main Results:
- A mathematical model simulating Aβ oligomer formation from monomeric Aβ.
- An optimal control problem formulation to estimate the nucleation rate.
- Identification of nucleation as a critical, yet unquantified, step in Alzheimer's pathogenesis.
Conclusions:
- The proposed optimal control method provides a novel approach to estimate the nucleation rate.
- Understanding and quantifying nucleation is crucial for validating the amyloid cascade hypothesis.
- This modeling approach offers insights into Alzheimer's disease mechanisms and potential therapeutic targets.

